By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioTime today said that it has reached an agreement with the California Institute for Regenerative Medicine to make five clinical-grade human embryonic stem cell lines available to California researchers.

Under terms of the agreement, BioTime will first provide research-grade cell lines. The Alameda, Calif.-based firm also plans within one year to provide GMP-grade cell lines along with certain documentation and complete DNA sequence information.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.